1. Candida pneumonia in a term infant after prolonged use of inhaled corticosteroids for bronchopulmonary dysplasia (BPD).
- Author
-
Buzzi E, Manzoni P, Castagnola E, Benjamin DK Jr, Beghini R, and Dall'agnola A
- Subjects
- Administration, Inhalation, Anti-Bacterial Agents therapeutic use, Antifungal Agents therapeutic use, Bronchopulmonary Dysplasia drug therapy, Candidiasis immunology, Humans, Infant, Infant, Newborn, Inhalation Exposure, Lung, Lung Diseases, Fungal immunology, Lung Diseases, Fungal therapy, Male, Oxygen Inhalation Therapy, Respiratory Insufficiency immunology, Respiratory Insufficiency microbiology, Respiratory Insufficiency therapy, Treatment Outcome, Bronchopulmonary Dysplasia complications, Candidiasis complications, Glucocorticoids adverse effects, Lung Diseases, Fungal microbiology, Term Birth
- Abstract
Candida spp. frequently cause invasive fungal disease in neonates, and many organs or apparatus can be involved through bloodstream dissemination. Though Candida spp. can heavily colonize the upper and lower respiratory tract, an end-organ localization to the lung is not frequent and acquisition via descending/respiratory route is a questioned entity. Here we report the case of a young infant affected by bronchopulmonary dysplasia (BPD) and treated with inhaled steroids who developed Candida pneumonia likely acquired through descending route., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF